The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
In their first treatment update since 2016, the World Health Organization (WHO) adopts a ‘treat all’ approach for hepatitis C, guided by the success of their HIV experience.
Dolutegravir’s first bump in the road to global roll-out begs larger questions around women’s rights and access to contraceptives at the International AIDS Conference (AIDS 2018).
Interim clinical trial results offer hope to people living with hepatitis C who stand to benefit from reduced price treatment, including the 2.3 million people who have HIV co-infection.
HIV self-testing leads to positive sexual behaviour change among Zambian female sex workers, according to new study.
Results from Latin America’s first PrEP demonstration project reveal that it is both feasible and effective as an HIV prevention method in the region. Will Brazil’s example pave the way for the rest of the region?
Women's risk of HIV significantly associated with key bacteria and their abundance in the vagina.
The 2020 goal of reaching 120 million additional girls and young women with modern contraceptives is likely to be missed, despite millions of new users.
As HIV drug resistance increases in low- and middle-income countries, getting people onto antiretroviral treatment means little in the long run if treatment programming is not also strengthened.
Testing for HIV is rising in the UK, but opportunities are being missed among some vulnerable groups.
South Africa’s national antiretroviral treatment programme has successfully reduced deaths and enabled people with HIV to maintain good health – but men are far less likely to benefit.
New research shows antiretroviral treatment radically reduces health inequalities – supporting arguments for scale-up of HIV treatment in low-resourced contexts.